Learn from Horizon 2020 to address unmet medical need in Europe
Viewpoint: BioMed Alliance Board member Prof. Ulrich Jaeger argues that EU funding is crucial in allowing medical researchers across member states to collaborate in the development of new treatments.
In Framework Programme 9, processes must be optimised and the budget boosted – to deliver for patients and the economy.
The full article can be found in Science Business.